$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

과민성 대장증후군 환자를 대상으로 수행된 한약 및 침구치료의 객관적 효과와 기전 연구에 대한 문헌고찰
Review on the Objective Effect and Mechanism Studies of Herbal Medicine, Acupuncture and Moxibustion Treatment for Irritable Bowel Syndrome Patients 원문보기

동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine, v.35 no.5, 2021년, pp.199 - 209  

노현덕 (부산대학교 한의학전문대학원 한의학과) ,  김민정 (부산대학교 한의학전문대학원 한의학과) ,  조임학 (부산대학교 한의학전문대학원 한의학과) ,  김소연 (부산대학교 한의학전문대학원 한의학과)

Abstract AI-Helper 아이콘AI-Helper

The purpose of this study was to explore objective indicators(outcomes) which are used to evaluate clinical efficacy and figure out the mechanisms of herbal medicine, acupuncture and moxibustion treatment for Irritable bowel syndrome(IBS). We searched randomized controlled trials(RCTs) that mediated...

주제어

표/그림 (8)

참고문헌 (52)

  1. Chang SJ, Kim JH, Min SY. A PubMed Literature Study of Korean Medicine Treatment (Acupuncture) in Irritable Bowel Syndrome. The journal of pediatrics of Korean medicine. 2018;32(3):119-30. 

  2. Han CW, Choi J-Y, Park SH, Kim SY. Experimental Study Trends on the Acupuncture Moxibustion Treatment for Visceral Hypersensitivity: Based on the Data of PubMed. Korean Journal of Acupuncture. 2019;36(2):93-103. 

  3. Foxx-Orenstein A. IBS-review and what's new. Medscape General Medicine. 2006;8(3):20. 

  4. Meizhe P, Siyu W, Xiang L, Si C, Wei L, Peiyi Z, et al. The Clinical and Experimental Study on Soothing Liver and Trengthening Spleen Intervention of Diarrhea-predominant Irritable Bowel Syndrome. World Traditional Chinese Medicine. 2014;9(12):1595-8. 

  5. Acosta A, Camilleri M, Linker-Nord S, Busciglio I, Iturrino J, Szarka LA, et al. A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016;22(1):69-77. 

  6. Hyun Sul Kim, Kim BJ. Latest Research Trends of Korean Medicine for the Treatment of Gastrointestinal Diseases. Korean J Oriental Physiology & Pathology. 2013;27(5):570-7. 

  7. Jones M, Chey W, Singh S, Gong H, Shringarpure R, Hoe N, et al. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Alimentary pharmacology & therapeutics. 2014;39(4):426-37. 

  8. Lembo A, Neri B, Tolley J, Barken D, Carroll S, Pan H. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Alimentary pharmacology & therapeutics. 2009;29(8):834-42. 

  9. Dae-Seog H, Soo-Young K, Ji-Eun P, Hyun-Ju S, Yoon-Jae L, Hee-Jung S, et al. NECA's guidance for undertaking systematic reviews and meta-analyses for intervention. research report. 2015;1(1):1-287. 

  10. Zhan DW, Sun JH, Luo KT, Xu LZ, Zhou JL, Pei LX, et al. Effects and efficacy observation of acupuncture on serum 5-HT in patients with diarrhea-predominant irritable bowel syndrome. Zhongguo zhen jiu [Chinese acupuncture & moxibustion]. 2014;34(2):135-8. 

  11. Liu YC. Clinical study of ascending-descending acupuncture method regulation of the spleen and stomach for treatment of Spleen Deficiency-type diarrhea in irritable bowel syndrome. Shanghai journal of acupuncture and moxibustion [shang hai zhen jiu za zhi]. 2015;34(1):25-7. 

  12. Cong L. Clinical Observation on Acupuncture Combined with Thunder-Fire Moxibustion in Treating IBS of Spleen-Deficiency Diarrhea. Journal of Chinese Medicine. 2020;48(03):56-60. 

  13. Liu-xiang H, Zhen L, Ling L. Effects of Tongxie Anpi Decoction Combined with Trimebutine Maleate Tablets on Serum 5-HT and CGRP in Patients with Diarrhea-predominant Irritable Bowel Syndrome with Hepatic Stagnation and Splenic Deficiency Chinese Journal of Experimental Formulas. 2016;22(05):188-91. 

  14. Wang SS, Wang XR, Yang RY, Xu Y, Li MY. Efficacy and mechanism of acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome of liver depression and spleen deficiency. Zhongguo zhen jiu [Chinese acupuncture & moxibustion]. 2020;40(6):605-9. 

  15. Chen-er Z, Feng P, Tao Z. A Clinical Study on Banxia Xiexin Decoction Treating Diarrhea Predominated Irritable Bowel Syndrome by Observing the Expression of Ghrelin. Chinese Journal of Traditional Chinese Medicine. 2011;29(11):2588-91. 

  16. Zhao J, Li H, Shi C, Yang T, Xu B. Electroacupuncture inhibits the activity of astrocytes in spinal cord in rats with visceral hypersensitivity by inhibiting P2Y1 receptor-mediated MAPK/ERK signaling pathway. Evidence-Based Complementary and Alternative Medicine. 2020;2020. 

  17. Lowe C, Aiken A, Day AG, Depew W, Vanner SJ. Sham acupuncture is as efficacious as true acupuncture for the treatment of IBS: A randomized placebo controlled trial. Neurogastroenterology and Motility. 2017;29(7). 

  18. Su-ping Y, Hui Y, Nan-lin H, Shu-qing D, Gao C. Effect of modified Sinisan on anorectal manometry of the constipation predominant type of irritable bowel syndrome. Chinese journal of integrative medicine. 2005;11(1):27-30. 

  19. Gao W, Wang C, Lin Y. Effect of jianpi tiaogan wenshen recipe in treating diarrhea-predominant irritable bowel syndrome. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi Chinese journal of integrated traditional and Western medicine. 2010;30(1):13-7. 

  20. Shen J, Zhu Q, Yuan Y. Effect of changji'an oral liquid on activated signal alterative intensity in algesthesia domain in patients with diarrhea type irritable bowel syndrome due to gan-pi disharmony. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhiChinese journal of integrated traditional and Western medicine. 2005;25(11):967-70. 

  21. Chu WCW, Wu JCY, Yew DTW, Zhang L, Shi L, Yeung DKW, et al. Does acupuncture therapy alter activation of neural pathway for pain perception in irritable bowel syndrome?: A comparative study of true and sham acupuncture using functional magnetic resonance imaging. Journal of Neurogastroenterology and Motility. 2012;18(3):305-16. 

  22. Schneider A, Weiland C, Enck P, Joos S, Streitberger K, Maser-Gluth C, et al. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome. Complementary therapies in medicine. 2007;15(4):255-63. 

  23. Xing-xing Z, Jian W, Li-xia P, Yi X, Bai Y, Shen-lin L. Efficacy of Jianpi Shugan Fomula on Intestinal Flora of Patients with Diarrhea Predominant Irritable Bowel Syndrome and Its Effect on Intestinal Flora. Chinese Journal of Experimental Formulas. 2019;25(13):79-86. 

  24. Sun X, Cai G, Wang W-J. Observation on intestinal flora in patients of irritable bowel syndrome after treatment of Chinese integrative medicine. Zhong xi yi jie he xue bao Journal of Chinese integrative medicine. 2004;2(5):340-2. 

  25. Wu XL, Wang YL, Sun JH, Shu YY, Pei LX, Zhou JL, et al. Clinical observation on acupuncture for diarrhea-predominant irritable bowel syndrome patients in syndrome of liver-stagnation and spleen-deficiency and its impact on Th1/Th2. Zhongguo zhen jiu [Chinese acupuncture & moxibustion]. 2013;33(12):1057-60. 

  26. Runhong Z. The effect of accupuncture-moxibustion treatment on serum IL-18, IL-23 and TNF-α level of elderly people with IBS. Chinese Journal of Gerontology. 2013;33(06):1435-6. 

  27. Sood R, Law GR, Ford AC. Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or'psychomarkers'? Nature Reviews Gastroenterology & Hepatology. 2014;11(11):683. 

  28. Aziz I, Tornblom H, Palsson OS, Whitehead WE, Simren M. How the change in IBS criteria from Rome III to Rome IV impacts on clinical characteristics and key pathophysiological factors. American Journal of Gastroenterology. 2018;113(7):1017-25. 

  29. W Wilson D, PS Hungin A, H Howse J, De Meester F, B Singh R, Wilczynska A, et al. Role of hormones and neuropeptides in IBS and other gastrointestinal disorders: understanding variability and chrononutrition. The Open Nutraceuticals Journal. 2011;4(1). 

  30. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clinical Gastroenterology and Hepatology. 2005;3(4):349-57. 

  31. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation-and diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2006;130(1):34-43. 

  32. Bearcroft C, Perrett D, Farthing M. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998;42(1):42-6. 

  33. Houghton L, Atkinson W, Whitaker R, Whorwell P, Rimmer M. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut. 2003;52(5):663-70. 

  34. Krejs GJ, Fordtran JS, Fischer J, Humphrey C, O'Dorisio T, Said S, et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology. 1980;78(4):722-7. 

  35. Love J, Szurszewski J. The electrophysiological effects of vasoactive intestinal polypeptide in the guinea-pig inferior mesenteric ganglion. The Journal of physiology. 1987;394(1):67-84. 

  36. Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Digestive diseases and sciences. 2004;49(7):1236-43. 

  37. Zhang H, Yan Y, Shi R, Lin Z, Wang M, Lin L. Correlation of gut hormones with irritable bowel syndrome. Digestion. 2008;78(2-3):72-6. 

  38. Simren M, Stotzer P-O, Sjovall H, Abrahamsson H, Bjornsson ES. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome. European journal of gastroenterology & hepatology. 2003;15(1):55-62. 

  39. Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, et al. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Scandinavian journal of gastroenterology. 2013;49(1):43-51. 

  40. Iwasaki M, Akiba Y, Kaunitz J. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system [version 1; peer review: 4 approved]. F1000Research. 2019;8(1629). 

  41. Bergman RA AA, Heidger PM. Plate 6.111 Vasoactive Intestinal Polypeptide (VIP) www.anatomyatlases.org2009-02-06 

  42. Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, et al. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Scand J Gastroenterol. 2014;49(1):43-51. 

  43. Qin G, Zhang Y, Yao SK. Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance. World J Clin Cases. 2020;8(9):1632-41. 

  44. El-Salhy M, Lillebo E, Reinemo A, Salmelid L. Ghrelin in patients with irritable bowel syndrome. International journal of molecular medicine. 2009;23(6):703-7. 

  45. YT P. Anorectal funtion test. Korean Journal of Neurogastroenterology and Motility. 1999;5(2). 

  46. Yuan Y-Z, Tao R-J, Xu B, Sun J, Chen K-M, Miao F, et al. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World journal of gastroenterology: WJG. 2003;9(6):1356. 

  47. Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. 2014. 

  48. Si J-M, Yu Y-C, Fan Y-J, Chen S-J. Intestinal microecology and quality of life in irritable bowel syndrome patients. World journal of gastroenterology: WJG. 2004;10(12):1802. 

  49. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. American Journal of Gastroenterology. 2005;100(2):373-82. 

  50. Kerckhoffs APM, Samsom... M. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. 2009. 

  51. Bashashati M, Rezaei N, Shafieyoun A, McKernan D, Chang L, Ohman L, et al. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterology & Motility. 2014;26(7):1036-48. 

  52. Yanqing L, Zhang H, Zuo X. Study on the shifting of Th1/Th2 balance of large intestinal mucosa in patients with irritable bowel syndrome. Chinese Journal of Digestion. 2001(12). 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로